Cobus Loots, CEO of Pan African Resources, on delivering sector-leading returns for shareholders. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksN4 Pharma Plc Regulatory News (N4P)

Share Price Information for N4 Pharma Plc (N4P)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 0.715
Bid: 0.65
Ask: 0.70
Change: 0.09 (14.40%)
Spread: 0.05 (7.692%)
Open: 0.625
High: 0.715
Low: 0.715
Prev. Close: 0.625
N4P Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Holding(s) in Company

8 Jan 2016 10:04

RNS Number : 2839L
Glenwick PLC
08 January 2016
 

 

TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES

1. Identity of the issuer or the underlying issuerof existing shares to which voting rights areattached:

GLENWICK PLC

2 Reason for the notification (please tick the appropriate box or boxes):

An acquisition or disposal of voting rights

X

An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached

An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments

An event changing the breakdown of voting rights

Other (please specify):

3. Full name of person(s) subject to thenotification obligation:

ONZIMA VENTURES PLC

4. Full name of shareholder(s)  (if different from 3.):

5. Date of the transaction and date onwhich the threshold is crossed orreached:

5 JANUARY 2016

6. Date on which issuer notified:

7 JANUARY 2016

7. Threshold(s) that is/are crossed orreached:

BELOW 3%

 

8. Notified details:

A: Voting rights attached to shares

Class/type ofshares

if possible usingthe ISIN CODE

Situation previousto the triggeringtransaction

Resulting situation after the triggering transaction

NumberofShares

NumberofVotingRights

Numberof shares

Number of votingrights

% of voting rights

Direct

Direct

Indirect

Direct

Indirect

ORD

50,000,000

50,000,000

40,000,000

40,000,000

2.9

B: Qualifying Financial Instruments

Resulting situation after the triggering transaction

Type of financialinstrument

Expirationdate

Exercise/Conversion Period

Number of votingrights that may beacquired if theinstrument isexercised/ converted.

% of votingrights

C: Financial Instruments with similar economic effect to Qualifying Financial Instruments

Resulting situation after the triggering transaction

Type of financialinstrument

Exercise price

Expiration date

Exercise/Conversion period

Number of voting rights instrument refers to

 

% of voting rights

 

 

 

Nominal

Delta

Total (A+B+C)

Number of voting rights

Percentage of voting rights

40,000,000

2.9%

 

9. Chain of controlled undertakings through which the voting rights and/or thefinancial instruments are effectively held, if applicable:

 

 

Proxy Voting:

10. Name of the proxy holder:

11. Number of voting rights proxy holder will ceaseto hold:

12. Date on which proxy holder will cease to holdvoting rights:

13. Additional information:

14. Contact name:

GAVIN BURNELL

15. Contact telephone number:

01279 821200

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
HOLSSISUAFMSEIF
Date   Source Headline
1st Jun 201611:34 amPRNHolding(s) in Company
26th May 20161:20 pmRNSHolding(s) in Company
20th Apr 201612:12 pmRNSHolding(s) in Company
20th Apr 20167:00 amRNSFiling of Patents by 49% - owned N4 Pharma
11th Apr 201610:03 amRNSSale of Investment
4th Apr 20168:57 amRNSUpdate re Investment
22nd Mar 20164:14 pmRNSInvestment
18th Mar 20161:55 pmRNSHolding(s) in Company
14th Mar 20169:44 amRNSInvestment
11th Mar 201612:49 pmRNSUpdate re Investment
10th Mar 20163:11 pmRNSInvestment
4th Mar 20161:05 pmRNSFurther information re N4 investment and update
1st Mar 201610:00 amRNSInvestment
8th Jan 201611:18 amRNSDisposal
8th Jan 201610:04 amRNSHolding(s) in Company
11th Dec 20153:34 pmRNSHolding(s) in Company
7th Dec 201511:07 amRNSInvestment
3rd Nov 20154:53 pmRNSDirector's Details - Update
15th Oct 20155:16 pmRNSChange of Name
14th Oct 20153:43 pmRNSResult of EGM
25th Sep 20157:00 amRNSNotice of EGM
23rd Sep 20155:11 pmRNSHalf Yearly Report
27th May 20157:00 amRNSNotice of AGM
12th May 20152:13 pmRNSFinal Results
2nd Dec 20143:14 pmRNSDirectorate Change
29th Sep 20149:37 amRNSHalf Yearly Report
22nd Sep 20143:00 pmRNSChange of Adviser
25th Jun 20143:23 pmRNSResult of AGM
28th May 20147:00 amRNSAvailability of Accounts and Notice of AGM
23rd May 20147:00 amRNSFinal Results
10th Sep 201312:07 pmRNSMexico Exhibition
2nd Sep 20137:00 amRNSSouth African Power Purchase Agreement
2nd Sep 20137:00 amRNSHalf Yearly Report
25th Jul 20137:00 amRNSOrder from the Kingdom of Saudi Arabia
1st Jul 20134:35 pmRNSResult of AGM
6th Jun 20137:00 amRNSNotice of AGM
12th Feb 20137:00 amRNSTrading Statement
16th Oct 20127:00 amRNSNew Solar Installation
12th Sep 20127:00 amRNSInterim Results
7th Sep 20127:00 amRNSChange of Nominated Adviser and Broker
27th Jun 20129:36 amRNSResult of AGM
29th May 20122:34 pmRNSNotice of AGM
8th May 20127:00 amRNSFinal Results
31st Jan 20127:00 amRNSTrading Update
17th Aug 20117:00 amRNSHalf Yearly Report
7th Jul 20117:00 amRNSResult of AGM, board change and change of name
30th Jun 20117:00 amRNSTotal Voting Rights
14th Jun 20117:00 amRNSIssue of Equity
9th Jun 20117:00 amRNSApproved installer status
2nd Jun 20117:00 amRNSNotice of AGM/proposed change of name

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.